The dual effectiveness removes the SEC review barrier for both the POS AM and the S-3 shelf. Monitor for any selling stockholder notices of intent to sell (Form 144 filings) and daily volume spikes on the OTCQB. The sheer size of the registered shares (795M vs. likely outstanding share count) suggests prolonged overhang. Watch for any subsequent takedown or prospectus supplement specifying pricing and volume.
Price Chart
Executive Summary
Two CytoDyn Inc. registration statements became effective on October 2, 2026: a POS AM (File No. 333-282000) and a new S-3 shelf (File No. 333-295250). The S-3 registers the resale of up to 794,972,289 shares (410,046,456 common shares plus 384,925,833 shares underlying warrants) by selling stockholders, with the company receiving no proceeds except from cash warrant exercises. The effectiveness removes the SEC review barrier, allowing immediate share sales into the market, creating significant dilution overhang for existing holders.
Key Facts
- Two EFFECT notices filed on 2026-10-02 for File Nos. 333-282000 (POS AM) and 333-295250 (new S-3 shelf).
- The S-3 registers the resale of up to 794,972,289 shares by selling stockholders — 410,046,456 common shares and 384,925,833 shares underlying warrants.
- Company receives no proceeds from share resales; only receives proceeds if warrants are exercised for cash.
- As of September 24, 2026, CYDY closed at $0.21 per share on the OTCQB.
- The S-3 was filed on September 25, 2026, and became effective 7 days later on October 2, 2026.
Financial Impact
Up to 794,972,289 shares registered for resale, representing massive potential dilution. At $0.21/share, the registered shares have a nominal value of ~$167M, but actual market impact depends on selling pace.
Risk Factors
- Massive dilution overhang from up to 795M shares registered for resale.
- No company proceeds from share resales — selling stockholders control timing and volume.
- OTCQB-listed stock with low liquidity may experience severe price pressure if selling begins in size.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (CYDY) — Batch item 1 | 9999999995-26-003138 |
| Document: 9999999995-26-003138-index.html | 9999999995-26-003140 |
| Document: 9999999995-26-003138.txt | 9999999995-26-003138 |
| EFFECT Filing (CYDY) — Batch item 4 | 9999999995-26-003140 |
| Document: 9999999995-26-003140-index.html | 9999999995-26-003138 |
| Document: 9999999995-26-003140.txt | 9999999995-26-003138 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | DEFA14A | $0.2500 $0.2500 | · 0.00% | ▼ −0.53% | $0.2600 (+4.00%) |
Oct 19, 2026 6d ago | 8-K | $0.2500 $0.2500 | · 0.00% | ▼ −0.53% | $0.2600 (+4.00%) |
Oct 8, 2026 18d ago | EFFECT | $0.2000 $0.2000 | · 0.00% | ▲ +0.60% | $0.2600 (−30.00%) |
Oct 5, 2026 21d ago | EFFECT | $0.2000 $0.2000 | · 0.00% | ▲ +0.55% | $0.2600 (−30.00%) |
Oct 5, 2026 21d ago | EFFECT | $0.2000 $0.2000 | · 0.00% | ▲ +0.55% | $0.2600 (−30.00%) |
Sep 25, 2026 4w ago | S-3 | $0.2200 $0.2000 | ▲ +9.09% | ▲ +8.91% | $0.2600 (−18.18%) |
Mar 5, 2026 33w ago | 8-K | $0.2400 $0.2300 | ▲ +4.17% | ▲ +2.85% | $0.2600 (−8.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers